Cheung Kong (Holdings) has applied to the stock exchange to spin off and list its biotechnology division on the Growth Enterprise Market. CK Life Sciences International (CKLS), a 60-40 joint venture ...
Cheung Kong (Holdings) could generate up to HK$2 billion in exceptional profits from the proposed spin-off of its biotechnology division on the Growth Enterprise Market. Goldman Sachs said its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results